Percent infarct mapping: An R1-map-based CE-MRI method for determining myocardial viability distribution

Magnetic Resonance in Medicine

Volumn 56, Issue 3, 2006, Pages 535-545

  Surányi, Pál ^a,d   Kiss, Pál ^a   Brott, Brigitta C ^b   Simor, Tamás ^a,d   Elgavish, Ada ^c,d   Ruzsics, Balázs ^a   Saab Ismail, Nada H ^d   Elgavish, Gabriel A ^a,b,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Elgavish Paramagnetics Inc   (United States)

Author keywords

Canine; Contrast agent; MI; MRI; Myocardial viability

Indexed keywords

BIOCHEMISTRY; CHLORINE COMPOUNDS; MAGNETIC RESONANCE IMAGING; MANAGEMENT INFORMATION SYSTEMS;

CANINE; CONTRAST AGENT; INTRINSIC PARAMETERS; LINEARLY PROPORTIONAL; LONGITUDINAL RELAXATION; MYOCARDIAL INFARCTION; MYOCARDIAL VIABILITY; TRIPHENYLTETRAZOLIUM CHLORIDES;

MAPPING;

CONTRAST MEDIUM; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOG; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HISTOCHEMISTRY; IMAGE DISPLAY; IMAGE INTENSIFIER; IMAGE PROCESSING; IMAGE QUALITY; IN VIVO STUDY; INFARCTION FRACTION; INVERSION RECOVERY; MALE; MEASUREMENT; MYOCARDIAL VIABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCENT INFARCT MAPPING; QUANTITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; RELAXATION TIME; REPRODUCIBILITY; SIGNAL DETECTION; SIGNAL INTENSITY; STATISTICAL ANALYSIS; TECHNIQUE; TIME;

EID: 33748344041     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.20979     Document Type: Article

References (44)

1. Beller GA. Noninvasive assessment of myocardial viability. N Engl J Med 2000;343:1487-1490.
2. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-379.
3. Travin M, Bergmann S. Assessment of myocardial viability. Semin Nucl Med 2005;35:2-16.
4. Balcells E, Powers ER, Lepper W, Belcik T, Wei K, Ragosta M, Samady H, Lindner JR. Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve. J Am Coll Cardiol 2003;41:827-833.
5. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
6. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223.
7. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102:1678-1683.
8. Choi SH, Lee SS, Choi SI, Kim ST, Lim KH, Lim CH, Weinmann H-J, Lim T-H. Occlusive myocardial infarction: investigation of bis-gadolinium mesoporphyrins-enhanced T1-weighted MR imaging in a cat model. Radiology 2001;220:436-440.
9. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-1089.
10. Kuhl HP, Beek AM, van der Weerdt AP, Hofman MB, Visser CA, Lammertsma AA, Heussen N, Visser FC, van Rossum AC. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003;41:1341-1348.
11. Watzinger N, Lund GK, Higgins CB, Wendland MF, Weinmann HJ, Saeed M. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling. J Magn Reson Imaging 2002;16:633-640.
12. Klein C, Nekolla S, Bengel F, Momose M, Sammer A, Haas F, Schnackenburg B, Delius W, Mudra H, Wolfram D, Schwaiger M. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-167.
13. Kramer C, Rogers W, Mankad S, Theobald T, Pakstis D, Hu Y. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000;36:1835-1840.
14. Rochitte CE, Lima JAC, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, Melin JA. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998;98:1006-1014.
15. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
16. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-1910.
17. Saeed M, Bremerich J, Wendland MF, Wyttenbach R, Weinmann H-J, Higgins CB. Reperfused myocardial infarction as seen with use of necrosis-specific vs. standard extracellular MR contrast media in rats, Radiology 1999;213:247-257.
18. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 2001;103:871-876.
19. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-2842.
20. Grebe O, Paetsch I, Kestler H, Herkommer B, Schnackenburg B, Hornbach V, Fleck E, Nagel E. Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction. J Cardiovasc Magn Reson 2003;5:575-587.
21. Amado LC, Gerber BL, Gupta SN, Rettmann DW, Szarf G, Schock R, Nasir K, Kraitchman DL, Lima JAC. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44:2383-2389.
22. Ibrahim T, Nekolla SG, Hornke M, Bulow HP, Dirschinger J, Schomig A, Schwaiger M. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 2005;45:544-552.
23. Setser R, Bexell D, O'Donnell T, Stillman A, Lieber M, Schoenhagen P, White R. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J Magn Reson Imaging 2003;18:434-441.
24. Fritz-Hansen T, Rostrup E, Ring PB, Larsson HB. Quantification of gadolinium-DTPA concentrations for different inversion times using an IR-turbo flash pulse sequence: a study on optimizing multislice perfusion imaging. Magn Reson Imaging 1998;16:893-899.
25. Messroghli D, Niendorf T, Schulz-Menger J, Dietz R, Friedrich M. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2003;5:353-359.
26. Simor T, Chu WJ, Johnson L, Safranko A, Doyle M, Pohost GM, Elgavish GA. In vivo MRI visualization of acute myocardial ischemia and reperfusion in ferrets by the persistent action of the contrast agent Gd (BME-DTTA). Circulation 1995;92:3549-3559.
27. Saab-Ismail NH, Simor T, Gaszner B, Lorand T, Szollosy M, Elgavish GA. Synthesis and in vivo evaluation of new contrast agents for cardiac MRI. J Med Chem 1999;42:2852-2861.
28. Kim SK, Pohost GM, Elgavish GA. Gadolinium complexes of [(myristoyloxy) propyl]diethylenetriaminetetraacetate: new lipophilic, fatty acyl conjugated NMR contrast agents. Bioconj Chem 1992;3:20-26.
29. Kim SK, Pohost GM, Elgavish GA. Fatty-acyl iminopolycarboxylates: lipophilic bifunctional contrast agents for NMR imaging. Magn Reson Med 1991;22:57-67.
30. Chu WJ, Elgavish GA. Gadolinium and dysprosium chelates of DTPA-amide-dextran: synthesis, 1H NMR relaxivity, and induced 23Na NMR shift. NMR Biomed 1995;8:159-163.
31. Chu WJ, Simor T, Elgavish GA. In vivo characterization of Gd(BME-DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function. NMR Biomed 1997;10:87-92.
32. Surányi P, Kiss P, Brott BC, Simor T, Elgavish A, Elgavish GA. Determining tissue kinetics of Gd(ABE-DTTA), an infarct-avid, persistent contrast-agent in canine myocardial infarction. In: Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 2004. p 1836.
33. Simor T, Gaszner B, Oshinski J, Waldrop S, Pettigrew R, Horvath I, Hild G, Elgavish G. Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart. J Magn Reson Imaging 2005;21:536-545.
34. Surányi P, Kiss P, Brott BC, Simor T, Elgavish A, Elgavish GA. Repeated, pixel-by-pixel T1-mapping in canine myocardial infarction, using an infarct-avid, persistent contrast agent, Gd(ABE-DTTA). In: Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 2004. p 172.
35. Messroghli D, Radjenovic A, Kozerke S, Higgins D, Sivananthan M, Ridgway J. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-146.
36. Fishbein M, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier J, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
37. Choi S, Jiang C, Lim K, Kim S, Lim C, Gong G, Lim T. Application of breath-hold T2-weighted, first-pass perfusion and gadolinium-enhanced T1-weighted MR imaging for assessment of myocardial viability in a pig model. J Magn Reson Imaging 2000;11:476-480.
38. Weiss CR, Aletras AH, London JF, Taylor JL, Epstein FH, Wassmuth R, Balaban RS, Arai AE. Stunned, infarcted, and normal myocardium in dogs: simultaneous differentiation by using gadolinium-enhanced cine MR imaging with magnetization transfer contrast. Radiology 2003;226:723-730.
39. Kiss P, Simor T, Lenard L, Hejjel L, Suranyi P, Saab-Ismail NH, Elgavish GA. Relaxivity of Gd.(ABE-DTTA) increases with magnetic field strength up to 5T. A contrast agent for high field imaging. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, HI, USA, 2002. p 10.
40. 13C spin-lattice relaxation measurements by inversion-recovery. J Magn Reson 1975;18:199-204.
41. Kaldoudi E, Williams SCR. Relaxation time measurements in NMR imaging. Part I: Longitudinal relaxation time. Concepts Magn Reson 1993;5:217-242.
42. Nekolla S, Gneiting T, Syha J, Deichmann R, Haase A. T1 maps by k-space reduced snapshot-FLASH MRI. J Comput Assist Tomogr 1992;16:327-332.
43. Dewey M, Kaufels N, Laule M, Schnorr J, Wagner S, Kivelitz D, Raynaud J, Robert P, Hamm B, Taupitz M. Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium. Magn Reson Med 2004;51:703-709.
44. Fallon J. Postmortem: histochemical techniques. In: GS W, editor. Myocardial infarction: measurement and intervention. Boston: Martinus Nijhoff Publishers; 1982. p 373-384.